Sanjivani Paranteral Limited has submitted its mandatory quarterly compliance certificate to BSE Limited, fulfilling regulatory requirements under SEBI (Depositories & Participants) Regulations, 2018. The certificate covers the fourth quarter and financial year ended March 31, 2026.

Regulatory Compliance Filing

The company filed the certificate on April 7, 2026, addressing the requirements under Regulation 74(5) of SEBI regulations. This regulation mandates companies to provide details of securities dematerialized and rematerialized during specified periods to stock exchanges where their shares are listed.

Registrar and Transfer Agent Confirmation

MUFG Intime India Private Limited, formerly Link Intime India Private Limited, serves as the company's Registrar and Transfer Agent. The firm provided the confirmation certificate required for compliance with SEBI regulations.

The registrar confirmed that securities received from depository participants for dematerialization during the quarter were properly processed according to prescribed timelines. All security certificates received were verified, mutilated, and cancelled following due verification procedures.

Quarter Activity Summary

A notable aspect of this filing is the absence of dematerialization activity during the reporting period. MUFG Intime India Private Limited specifically noted that no requests were received from shareholders for dematerialization during the quarter ended March 31, 2026.

Corporate Governance

The certificate was signed by Ravikumar Bogham, who serves as Company Secretary cum Compliance Officer for Sanjivani Paranteral Limited. The digital signature was applied on April 7, 2026, ensuring proper authentication of the regulatory filing.

This quarterly filing demonstrates the company's commitment to maintaining regulatory compliance and transparent reporting to stock exchanges and regulatory authorities.

Sanjivani paranteral Limited has filed its mandatory annual disclosure with BSE Limited under SEBI's takeover regulations for the financial year ended 31st March, 2026. The pharmaceutical company submitted the required documentation on 2nd April, 2026, ensuring compliance with regulatory obligations.

Regulatory Compliance Details

The disclosure was made pursuant to Regulation 31(4) of the Securities Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Company Secretary Cum Compliance Officer Ravikumar Bogham submitted the filing to BSE Limited, which trades the company's shares under scrip code 531569.

Promoter Group Declaration

Promoter and Chairman Cum Managing Director Ashwani Khemka provided a comprehensive declaration on behalf of the promoter and promoter group. The declaration specifically confirmed that no encumbrance was made, directly or indirectly, over the company's shares during the financial year ended 31st March, 2026.

The promoter group declaration covered all members of the promoter and promoter group, including persons acting in concert with Sanjivani Paranteral Limited. This comprehensive coverage ensures full transparency regarding share ownership and potential encumbrances.

Corporate Governance Framework

The filing demonstrates the company's commitment to maintaining robust corporate governance standards and regulatory compliance. The disclosure was addressed to both BSE Limited's Corporate Relationship Department and the company's Audit Committee, ensuring proper oversight and documentation.

Sanjivani Paranteral Limited operates from its registered office at 205 P-N Kothari Industrial Estate, B S Marg Bhandup (W), Mumbai-400078, Maharashtra. The timely submission of this annual disclosure reflects the company's adherence to SEBI's substantial acquisition and takeover regulations.